Catalyst Clinical Research Acquires Aptus Clinical to Accelerate European Expansion, Broaden Client Services, and Enhance Patient Impact
The transaction capitalizes on the two company’s combined geographic strengths, complementary service offerings and therapeutic expertise to advance industry-leading research for improved patient outcomes. WILMINGTON, N.C., ALDERLEY PARK, U.K, 4 May 2022 – Today,...
Catalyst Names Niklas Morton as First Chief Operating Officer
Veteran Biotech Executive Will Direct Operations, Help Shape Growth Strategy Wilmington, NC, 5 April 2022 – Niklas Morton, a seasoned industry executive with extensive experience at PPD and SmithKline Beecham (now GSK), has joined Catalyst Clinical Research as chief...
Catalyst Clinical Research, Ledger Run Expand Strategic Partnership To Accelerate Research, Streamline Clinical Operations
Catalyst Streamlines Business Processes with New Technologies Wilmington, NC and Tiburon, CA – 8 February 2022 – Catalyst Clinical Research, a leading provider of clinical research services, and Ledger Run, a leading innovator in clinical operations technology, will...
Catalyst CEO Nick Dyer Named to 2021 ‘Wilmington Biz 100,’ Described as Community ‘Innovator’
Wilmington Business Publication Highlights Accomplishments of Regional Leaders Wilmington, NC, 8 December 2021 – Catalyst CEO Nick Dyer was recognized as one of Wilmington’s top business leaders in 2021 by the WilmingtonBiz publication. Catalyst is headquartered...
